[Systemic lupus erythematosus during therapy with oral estrogen-progestin. Considerations apropos of a case].
Gueli
N
N
Toto
A
A
Tartaglione
E
E
Lucianetti
M C
MC
Screnci
M
M
Sauli
V
V
Carmenini
G
G
D000328:Adult; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009644:Norgestrel / Q000009:adverse effects*; D011282:Pregnenediones / Q000627:therapeutic use
D003278:Contraceptives, Oral, Hormonal; D011282:Pregnenediones; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; C021988:deflazacort
Lupus eritematoso sistemico in corso di terapia con estroprogestinici orali. Considerazioni a proposito di un caso.